Multimodal Phantom of Liver Tissue by Chmarra, Magdalena Karolina et al.
Multimodal Phantom of Liver Tissue
Magdalena K. Chmarra1*, Rune Hansen1,2, Ronald Ma˚rvik3,4, Thomas Langø2
1Department of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway, 2Department of Medical
Technology, SINTEF Technology and Society, Trondheim, Norway, 3Department of Gastrointestinal Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim,
Norway, 4National Center for Advanced Laparoscopic Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
Abstract
Medical imaging plays an important role in patients’ care and is continuously being used in managing health and disease.
To obtain the maximum benefit from this rapidly developing technology, further research is needed. Ideally, this research
should be done in a patient-safe and environment-friendly manner; for example, on phantoms. The goal of this work was to
develop a protocol and manufacture a multimodal liver phantom that is suitable for ultrasound, computed tomography,
and magnetic resonance imaging modalities. The proposed phantom consists of three types of mimicked soft tissues: liver
parenchyma, tumors, and portal veins, that are made of six ingredients: candle gel, sephadexH, agarose, glycerol, distilled
water, and silicone string. The entire procedure is advantageous, since preparation of the phantom is simple, rather cost-
effective, and reasonably quick – it takes around 2 days. Besides, most of the phantom’s parts can be reused to manufacture
a new phantom. Comparison of ultrasound images of real patient’s liver and the developed phantom shows that the
phantom’s liver tissue and its structures are well simulated.
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Introduction
Currently, one of the fastest developing areas within medicine,
both in clinical settings and in research and development, is
medical imaging [1]. Medical imaging can be defined as a set of
techniques that, in most of the cases, provide images of the internal
parts of the body in a noninvasive manner. The term ‘‘noninva-
sive’’ means here that imaging modalities do not penetrate the skin
physically. Medical imaging covers various imaging modalities,
including ultrasound (US), x-ray-based methods (e.g. radiography
and computed tomography (CT)), magnetic resonance (MR),
nuclear medicine (e.g. positron emission tomography (PET) and
single photon emission computed tomography (SPECT)), and
other methods in optical imaging [1].
Medical imaging plays an important role in patients’ care and is
continuously being used in managing health and disease [2], [3].
For example, it is used in prevention, early detection of disease,
choosing an optimal treatment, during surgical interventions,
monitoring of treatment effects, etc. [3]. During surgical interven-
tions, the imaging modality has to be readily available and
preferably provide images in real-time for optimal guidance. To
allow further development of image-guided therapeutic interven-
tions and diagnostic imaging techniques and systems, phantoms
that simulate human or animal tissue are needed.
Most of the commercially available phantoms are adapted for a
broad market and are designed for particular applications [4].
Those phantoms are rather expensive and they are not meant to
be modified or custom-fitted by the users [4]. To customize design
and fabrication of the phantoms, and to overcome the above-
mentioned disadvantages, various studies focus on development of
techniques and ingredients to prepare tissue-mimicking materials
[4–9].
In the literature, a multitude of techniques and tissue-mimicking
materials have been proposed to prepare phantoms. The most
often-used bulk matrix materials for mimicking soft tissue are
based on: aqueous suspensions, agarose, gelatin, magnesium-
silicate, oil gel, polyacrylamide gel, polyurethane resin, polyvinyl
alcohol (PVA), polyester resin, epoxy resin, polysaccharide gels
TX-150 and TX-151, polyacrylamide, and Room-Temperature-
Vulcanizing (RTV) silicone [4], [5], [10]. Aqueous suspensions are
the simplest tissue substitutes, in which water is used as a substitute
of a tissue. Agarose- and gelatin-based tissue substitutes (also called
hydrogels) are the most widely used alternatives of soft tissue that
are described in the literature [4], [5]. The reasons for that are:
well-characterized performance, ease of fabrication, and flexibility
provided by the process that allows achieving a range of acoustic
properties [4]. Reported main disadvantages of using both
agarose- and gelatin-based phantoms are their lack of longevity
(often limited to less than one month because of microbial
invasion), and delicate structure that can easily be damaged [10].
Inclusion of biochemically toxic species prevents bacterial growth
in these two tissue-mimicking materials. Oil gel-based substitutes
consist of a propylene glycol, a gelatinizer, and 10 mm polymethyl
methacrylate microspheres [11]. Their main advantages are:
resistance to bacterial infection, and linear increase of speed of
sound and attenuation with the proportion of propylene glycerol.
Ethylene glycol-based oil gels, however, are not perfect substitutes
of soft tissue for multimodal phantoms, because of their US
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characteristics; i.e. speed of sound and density are too high, and
attenuation is too low. Polyurethane, polyester and epoxy resins
have been reported to have good characteristics for mimicking soft
tissue, including low Young’s modulus, elastic recovery and
immunity to bacterial infection [11]. The standardization of the
polyurethane gel-based phantoms production, however, is prob-
lematic due to complex molecular design of the gels. PVA-based
tissue substitutes (also referred as cryogels) have indefinite
longevity, are low cost, and require a smaller amount of
ingredients than the agarose- and gelatin-based tissue substitutes
[12], [13]. Preparation of the PVA-based phantoms requires
multiple 12-h freeze-thaw cycles and precise control of the
temperature. Polysaccharide gels are used to prepare an inexpen-
sive, conveniently moldable, and temporally stable tissue equiva-
lent [14]. Using polysaccharide gels requires controlling gelling
time by means of temperature and the ratio of the polysaccharide
gel to water. Often encountered problem when making this gel
mixture is incorporation of bubbles, which is a problem for US
imaging. Polyacrylamide gel-based tissue substitutes are made by
polymerization of the acrylamide monomer [15]. Since polyacryl-
amide is highly toxic, special precautions during its preparations
are needed. The advantage of using RTV silicone is that the
phantoms can be quickly produced [16]. Besides, RTV silicone
provides a soft rubber texture similar to that of stiff tissue. The
major two shortcomings of using this material are cost and
hardening time.
Next to choosing bulk matrix materials, scattering particles need
to be selected for optical phantoms. Often, this selection is made
separately from the choice of the matrix structure. The four most
common choices of scattering agents are: lipid microparticles,
polymer microparticles, white metal oxide powders (including
TiO2 and Al2O3 powders), and quartz glass microspheres. Lipid
microparticles of 10 to 500 nm are biologically analogous to
bilipid membranes of cells and organelles, which are believed to
cause scattering in tissue. Commercially available lipid-based
scatterers are milk [17], [18], fat/oil/lipid [19] and Intralipid/
Nultralipid [20–22]. Polymer microspheres of 50 to 100 mm are
produced in regular sizes, which means that repeatability and
predictions of spectra are good due to well-controlled size and
index of refraction [10], [23]. Wide availability of TiO2 powder,
20 to 70 nm, makes titanium dioxide one of the most commonly
used scatterers. The key drawback of the TiO2 powder is that it
settles when not stirred, which is a problem when fabricating
aqueous suspensions. Therefore, TiO2 powders should be used for
manufacturing gelatin- or agarose-based, RTV, and resin phan-
toms. The use of quartz glass microspheres (250 nm) is less
established [10].
The goal of this work was to develop a protocol and
manufacture a multimodal liver phantom. The main requirements
for the phantom were: suitability for US, CT, and MR imaging
modalities; easy production; standardized fabrication; low cost;
and life-cycle environment friendliness, including re-usability of
phantom’s parts and materials, and avoidance of using toxic
resources.
The developed protocol is a combination and modification of
procedures proposed by Fredfeldt [24] and Schweiger et al. [25].
The phantom consists of three types of mimicked soft tissues: liver
parenchyma, tumors, and portal veins. The main ingredient of the
liver parenchyma is candle gel. To obtain homogeneous and
adequate echogenicity of the parenchyma, sephadexH has been
equally distributed in it. The tumors have been made of a mixture
of agarose, sephadex, glycerol, and distilled water. Agarose has
been chosen for its low attenuation of US beams, and to obtain a
bulk-like substance. Besides, agarose is a good T2-relaxation
modifier in MR imaging. Sephadex allows for obtaining homo-
geneous and adequate background US scattering, whereas glycerol
helps to obtain adequate speed of US. Distilled water makes up the
remaining volume needed for tumor tissue. Star shape cross-
sectioned silicone cords have been chosen to mimic the portal
veins.
Materials and Methods
The compositions of the materials used for mimicking those soft
tissues and the whole equipment needed to manufacture
multimodal phantom are described below. In the section Reagents,
essential materials used to produce the phantom are split into
reagents. In Reagent Setup, details of composition of buffers are
given. Section Equipment provides the reader with a description of
all equipment needed. In the section Protocol, a detailed method to
manufacture the phantom is described together with timing,
critical steps, pause points, and troubleshooting.
A choice of concentrations of ingredients in both liver
parenchyma and tumor tissue was obtained after a series of
iterations that involved varying the concentrations of all the
ingredients and assessing obtained US, CT, and MR images.
Reagents
N Candle gel (www.panduro.com)
N Sephadex (Fine, 20–80 mm, Sephadex G2580, Sigma-Aldrich,
www.sigmaaldrich.com)Figure 1. Silicone molds for manufacturing tumors.
doi:10.1371/journal.pone.0064180.g001
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‘CAUTION’ The toxicological properties of this material have
not been fully investigated. May cause eye, skin, and respiratory
tract irritation.
N Agarose (Type I-A, low EEO, Agarose A0169, Sigma-Aldrich,
www.sigmaaldrich.com)
N Glycerol (99% GC, Sigma-Aldrich, www.sigmaaldrich.com)
‘CAUTION’ Avoid contact and inhalation: Target organ(s):
Kidneys. Hygroscopic.
N Distilled water
N If required: pigments for candle gel (www.panduro.com) and/
or food dyes for agarose-based mixture (http://www.wilton.
com)
‘CRITICAL’ Use pigments for candle gel or food dyes for
agarose-based mixture if coloration of liver parenchyma or tumors
is needed. Note, adding a higher amount of pigments to candle gel
will decrease the transparency of the liver parenchyma.
Reagent Setup
Carpet. Cut the carpet in the form of the bottom of the
phantom container.
Tumor tissue. The tumor tissue is made of 7.5 g of agarose,
30 ml of glycerol, 200 ml of distilled water, and 4 g of sephadex.
The tumor tissue can be prepared in one week in advance and
stored in the fridge.
Liver parenchyma. Liver parenchyma is made of 1000 g of
candle gel and 4.2 g of sephadex. The parenchyma can be made
months in advance and stored in congealed form at a room
temperature. Before preparing a phantom, the parenchyma should
be heated up (while gently stirring) until it becomes liquid. Then, it
should be placed in the vacuum drying oven.
Equipment
Note that the equipment described below is the one available in
our laboratory. Nevertheless, all this equipment can be modified
according to needs and preferences of the reader.
N Graduated cylinder
N Erlenmeyer (conical) flask
N Beaker
N Spatulas
N Silicone molds for making tumors (tumor diameter = 10 mm,
prepared at the Dept. Medical Techniques at St. Olavs
Hospital, Trondheim) (Fig. 1)
N Lab scale (readability 1 mg, Sartorius, http://www.sartorius.
com)
N Lab scale (readability 1 g, Sartorius, http://www.sartorius.
com)
N Laboratory hot plate magnetic stirrer (MR Hei-Standard,
Heidolph Instruments, http://www.heidolph-instruments.
com)
N Magnetic stirrer bars
N Vacuum drying oven (B8000, Termaks, http://www.termaks.
com)
N Phantom container (Le´kue´ duo loaf spring form with
removable base, duo rectangular, 24 cm, Le´kue´, www.lekue.
es) (Fig. 2)
We recommend using a silicone mold if the phantom should
easily be removed from the phantom container. Use a plastic box
if the phantom should be kept in the phantom container and if it is
required to, for example, apply CT or MR fiducial markers on it.
N Silicone string (internal diameter = 2 mm, outside diame-
ter = 2.9 mm, Master Class Silicone Kitchen Twine, Kitchen
Craft, www.kitchencraft.co.uk) (Fig. 3).
Figure 2. Silicone phantom container with carpet. Left: open container; Right: closed container.
doi:10.1371/journal.pone.0064180.g002
Figure 3. Silicone string for mimicking portal veins.
doi:10.1371/journal.pone.0064180.g003
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To mimic portal veins, we recommend using silicone string with
a star-shaped cross-section.
N Carpet
We recommend using carpet to avoid specular reflections from
the bottom of the phantom container and the surface on which the
phantom container is placed.
Procedure
Preparation of the Phantom Container
TIMING,1 day.
1. Place the carpet in the phantom container (Fig. 2).
2. Pour hot water onto the carpet (just to cover the whole carpet),
cover the phantom container, and leave it for approximately
24 hours.
‘CRITICAL STEP’ Air bubbles left in the carpet cause
reflections in the ultrasound images. They also cause development
of air bubbles in the phantom’s parenchyma. Remove all air
bubbles from the wet carpet by gently wiping carpet’s surface with
fingers.
Preparation of the Tumor Tissue
TIMING,2 h.
1. Place agarose, distilled water and glycerol in a conical flask
together with a stirring magnetic bar.
2. Place the conical flask on the hot plate magnetic stirrer and
heat it up under magnetic steering at the maximum speed of
250 rotations/minute.
‘CRITICAL STEP’ Ensure that stirring the mixture does not
promote development of air bubbles.
1. Boil the agarose mixture for around 2 minutes.
2. Add sephadex (while stirring).
‘CRITICAL STEP’ Distribute sephadex in a small quantity of
the agarose mixture first. Once the sephadex is equally distributed,
pour the mixture to the rest of the agarose mixture.
Table 1. Troubleshooting.
Step Problem Possible reason Solution
11 The shape of tumor does not
resemble mold’s cavity
Too thick agarose-based mixture Repeat the preparation of the tumor tissue. In step 8, pour the
mixture into the molds when it has a higher temperature than
40uC
20 Big air bubbles Air bubbles left in the carpet Use spatula to gently move the air bubbles towards phantom
container’s walls
Air bubbles introduced during preparing
candle gel mixture
Use spatula to gently move the air bubbles towards phantom
container’s walls. Place remaining candle gel mix in the
vacuum drying oven for 0,5 h
Air bubbles introduced during pouring
candle gel mixture
Use spatula to gently move the air bubbles towards phantom
container’s walls. Reduce the speed of pouring the gel in the
phantom container
24 Big air bubbles Air bubbles introduced during preparing
candle gel mixture
Use spatula to gently move the air bubbles towards phantom
container’s walls. Place remaining candle gel mix in the
vacuum drying oven for 0,5 h
Air bubbles introduced during pouring
candle gel mixture
Use spatula to gently move the air bubbles towards phantom
container’s walls. Pour successive candle gel layers via the
surface of the phantom container’s wall. Reduce the speed of
pouring the gel in the phantom container
Air bubbles from the surface of the tumors Use spatula to gently move the air bubbles towards phantom
container’s walls. Consider making new tumors
Small air bubbles Air bubbles introduced during pouring
candle gel mixture
Use spatula to gently move the air bubbles towards phantom
container’s walls. Pour successive candle gel layers via the
surface of the phantom container’s wall
Air bubbles from the surface of the tumors Use spatula to gently move the air bubbles towards phantom
container’s walls. Consider making new tumors
doi:10.1371/journal.pone.0064180.t001
Figure 4. Manufacturing multimodal phantom. Left: step 19 of the protocol; Middle: step 22 of the protocol; Right: the end result of the
protocol – multimodal phantom mimicking liver tissue.
doi:10.1371/journal.pone.0064180.g004
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‘CRITICAL STEP’ Ensure that stirring the mixture does not
promote development of air bubbles. The stirring speed, however,
should be sufficiently high to ensure that high-density sephadex
does not settle.
1. If required: add pigments while gently stirring the mixture.
2. Cool the agarose mixture to around 40uC while continuously
stirring.
3. Pour the agarose mixture into the tumor molds.
4. Place the tumor molds in the fridge for at least 0.5 hour.
‘PAUSE POINT’ Can be left up to one week in the fridge.
1. Remove the agarose-based tumors from the tumor molds.
‘CRITICAL STEP’ It is recommended not to keep the agarose-
based tumors for longer than one hour in the room temperature.
‘TROUBLESHOOTING’ Troubleshooting advice can be
found in Table 1.
Preparation of the Liver Parenchyma
TIMING,3.5 h.
1. Place candle gel together with a magnetic stirring bar in a
beaker.
2. Place the beaker on the hot plate magnetic stirrer and heat it
up until candle gel becomes liquid (around 80–90uC).
3. Distribute sephadex in the liquid candle gel.
‘CRITICAL STEP’ Distribute sephadex in a small quantity of
the candle gel first. Once the sephadex is equally distributed, pour
the mixture to the rest of the candle gel. Use magnetic stirring to
equally distribute the mixture in the candle gel.
1. Place the candle gel mixture in the vacuum drying oven (at
around 80–90uC) for at least 2 hours.
‘CRITICAL STEP’ This step is recommended in order to
remove air bubbles from the candle gel mixture.
‘PAUSE POINT’ Candle gel mixture can be left overnight in
the vacuum drying oven (at around 80–90uC).
1. Place the candle gel mixture on the hot plate magnetic stirrer
and gently stir it (at maximum speed of 250 rotations/minute)
for about 1 minute.
‘CRITICAL STEP’ High-density sephadex settles down when
the candle gel mixture is kept in the vacuum drying oven. Stir
gently the mixture to equally distribute sephadex in it.
1. If required: add pigments while gently stirring the mixture.
Preparation of the Phantom
TIMING,12 h.
1. Remove the excessive amount of water from the phantom
container.
2. Pour a thin layer of the candle gel mixture into the phantom
container.
‘CRITICAL STEP’ Cover the whole carpet with the candle gel
mixture (Fig. 4). This will lock the remaining air bubbles in the
Figure 5. Visualization of CT and MR images of the phantom. Left: 3D volume rendering of the CT data with low-level threshold to remove
the ‘‘parenchyma’’ (candle gel component). Middle column: Orthogonal slices through the CT volume at the position indicated by the yellow cross in
the 3D rendering, axial, coronal and sagittal slices (top to bottom). Right column: Corresponding MR slices from the MR volume data at the same
position in the phantom. No thresholding has been applied to the MR data.
doi:10.1371/journal.pone.0064180.g005
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carpet and will avoid their distribution into the next layers of the
candle gel mixture.
‘CRITICAL STEP’ Gently pour the candle gel mixture into the
phantom container from one corner. The candle gel mixture will
spread itself on the surface without introducing additional air
bubbles.
1. Use a spatula to remove any air bubbles that have been
introduced during step 19.
‘CRITICAL STEP’ Remove the air bubbles when the candle
gel mixture (liver parenchyma) is still liquid. It is not recom-
mended to remove air bubbles when the candle gel mixture is half-
congealed, as in most of the cases it will result in expanding the air
bubbles.
‘CRITICAL STEP’ Remove the air bubbles by gently moving
them towards phantom container’s walls.
‘TROUBLESHOOTING’ Troubleshooting advice can be
found in Table 1.
1. Place the phantom in the fridge for around 15 minutes.
2. Remove the phantom from the fridge and place agarose-based
tumors and/or silicone blood vessels on the liver parenchyma
(Fig. 4).
3. Pour a layer of the liver parenchyma carefully, trying not to
introduce air bubbles.
‘CRITICAL STEP’ Pour the candle gel mixture into the
phantom container from one corner. The candle gel mixture will
spread itself on the surface without introducing additional air
bubbles.
‘CRITICAL STEP’ Do not make too thick layers, as they will
cause longer congelation time and will keep higher temperature of
the phantom for a longer time. This might cause changes in forms
of the agarose-based tumors. The best results are obtained with the
layers’ thickness of 1–2 cm.
1. Use a spatula to remove the air bubbles that have been
introduced during step 22.
Figure 6. Orthogonal slicing through a 3D ultrasound volume and the MR volume data. From top to bottom: axial, coronal and sagittal
slices. The tumor model has a silicone string going into it, representing a portal vein, as can be seen in the coronal slice in both ultrasound and MR.
doi:10.1371/journal.pone.0064180.g006
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Figure 7. The original MR, CT, and US images from the phantom and patients along with the cropped regions.
doi:10.1371/journal.pone.0064180.g007
Multimodal Phantom
PLOS ONE | www.plosone.org 7 May 2013 | Volume 8 | Issue 5 | e64180
‘CRITICAL STEP’ Remove the air bubbles when the candle
gel mixture (liver parenchyma) is still liquid. It is not recom-
mended to remove air bubbles when the candle gel mixture is half-
congealed, as in most of the cases it will result in expanding the air
bubbles.
‘CRITICAL STEP’ Remove the air bubbles by gently moving
them towards phantom container’s walls.
‘TROUBLESHOOTING’ Troubleshooting advice can be
found in Table 1.
1. Place the phantom in the fridge for about 15–30 minutes.
2. Repeat steps 22 to 25 as long as needed, depending on the
design of the phantom, e.g. the position (height) of the tumors
and blood vessels in the parenchyma.
3. Place the phantom in the fridge for at least 6 hours.
Results and Discussion
Figure 4 presents a phantom developed using above described
procedure. The US, CT and MR images of the phantom are
shown in Fig. 5 and Fig. 6. The following protocols were used to
scan the phantom:
N CT: liver, slice thickness 1 mm, distance between slices
0.5 mm
N MR: T1, slice thickness 1 mm, distance between slices 1 mm.
Ultrasound images were obtained using a laparoscopic ultra-
sound probe (OL531, Hitachi, Japan). As seen in the figure,
sephadex is equally distributed in the candle gel. Besides, there are
no visible borders between the layers of the liver parenchyma.
The liver model has been positively evaluated by four expert
surgeons who have done a high number of liver resection, both
open and laparoscopically, radiologists, and engineers who work
on medical imaging. Comparison of ultrasound images of real
patient’s liver [26] and the developed phantom shows that the
phantom’s liver tissue and its structures are well simulated. Also
CT and MR images show that simulated tissues are similar to
those of a real patient [26]. The original images from the phantom
and patient data along with cropped regions are shown in Fig. 7.
The patient sample images (MR, CT, and US) are from a patient
with a metastasis in the liver. The MR imaging protocol used was
a T1 weighted liver protocol.
The proposed protocol allows manufacturing multimodal
phantoms that have reusable parts. Apart from tumors, both liver
parenchyma and portal veins can be reused to fabricate a new
phantom. For that, the ‘‘old’’ phantom needs to be disassembled.
Disassembling of the phantom is rather easy, since removing of the
agarose-based tumors and silicone portal veins is an effortless
process.
Removed silicone portal veins should be cleaned before using
them in a new phantom. For that, hot water can be used. The
candle gel based liver parenchyma can be stored in the congealed
form at a room temperature. To reuse the liver parenchyma, it is
necessary to heat it up until it is liquefied.
The protocol has been developed such that it permits
modifications of the phantom’s content. For example, manufac-
turing phantoms for developing methods to identify micro-
calcifications in healthy tissues requires replacement of the
agarose-based tumors and silicone portal veins by calcium particles
of 40–190 mm. This is useful for research on ultrasound-based
diagnostics in breast.
The limitations of our protocol are related to the challenges of
incorporating exact representations of vessels as different types,
e.g. portal and hepatic veins, are portrayed slightly different in US
images. Further research is required to refine and enable the
representation of various lesions in organs in our phantom/
protocol. Our protocol can be used to represent some typical
lesions, but not all of them.
The developed protocol was meant for manufacturing phan-
toms for research purposes that include work on early diagnoses of
diseases (including new methods for identifying micro-calcifica-
tions in healthy tissue [27]), evaluation of and work on navigation
system (CustusX [28]), development of training setups for
acquiring US skills and training and validation of navigated
ultrasound in laparoscopic surgery. The advantage of using
phantoms is that they are designed to mimic tissue characteristics
that include acoustic properties, dimensions, and internal features.
As a consequence, the phantoms can provide users with a
simplified and standardized environment. There are, therefore,
various purposes for which multimodal phantoms can be used.
Those include:
N Initial tests of designed imaging systems
N Characterization and optimization of existing imaging systems
N Calibration and routine quality control of imaging systems
N Comparison of performance between imaging systems
N Establishment of appropriate training for translation of new
imaging technologies in the clinical practice
N Training means for surgeons before performing live surgery
such as US-guided puncture of lesions (e.g. biopsy or
placement of radio frequency needle)
N Training means for surgeons to learn to navigate in 3D
volumes
N Training means for novices to learn US tissue characterization
and US anatomy
N Optimization of existing imaging technologies for clinical
practice
N Testing in development of navigation systems targeted for
various clinical applications, where the phantom can be
tailored to fit the target organ(s)
N Assessment of 3D US acquisition and reconstruction based on
knowledge about sizes and shapes of the phantom constituents
both from the production and from CT and/or MR images.
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